Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Study identifies mechanisms by which COVID-19 can lead to Alzheimer's disease-like dementia

A new Cleveland Clinic-led study has identified mechanisms by which COVID-19 can lead to Alzheimer's disease-like dementia.

11 Jun 2021

Study: cis P-tau is an early marker of vascular dementia, Alzheimer's disease

Researchers remain perplexed as to what causes dementia and how to treat and reverse the cognitive decline seen in patients.

11 Jun 2021

Experts call for new standards to prevent noise-induced hearing loss in younger generations

As more and more people are taking advantage of music on the go, personal audio systems are pumping up the volume to the detriment of the listener's hearing. Children, teenagers, and young adults are listening to many hours of music daily at volumes exceeding the globally recommended public health limit of 70 decibels of average leisure noise exposure for a day for a year.

11 Jun 2021

Age influences the extent to which smoking and other risk factors increase risk of depression

People who smoke, suffer from high blood pressure, obesity, or diabetes are not only at greater risk of suffering a stroke, heart attack, or dementia.

10 Jun 2021

Systemic biomarkers show beneficial effects of aerobic exercise on brain function in older adults

Increasing evidence shows that physical activity and exercise training may delay or prevent the onset of Alzheimer's disease (AD). In aging humans, aerobic exercise training increases gray and white matter volume, enhances blood flow, and improves memory function.

10 Jun 2021

Study reveals new insights into how genes are regulated in dementia

The largest study of its kind has unveiled new insights into how genes are regulated in dementia, including discovering 84 new genes linked to the disease.

10 Jun 2021

Nose-to-brain: Nasal delivery of biopharmaceuticals to the brain

Placing medications as close as possible to the site of the disease: This sounds completely believable in theory, but is unfortunately not so simple in practice. While this works well for many drugs via the bloodstream or the digestive tract, it does not apply to the brain.

9 Jun 2021

Having trouble falling asleep associated with cognitive impairment 14 years later

A study of nearly 2,500 adults found that having trouble falling asleep, as compared to other patterns of insomnia, was the main insomnia symptom that predicted cognitive impairment 14 years later.

9 Jun 2021

Healthy behaviors can prevent dementia, finds study

A new Alzheimer's disease drug will hit the market soon, the first in nearly two decades. But some experts say the evidence for it isn't terribly strong and worry that it may cost a lot.

9 Jun 2021

New study has implications for research and advancements in Alzheimer’s and related memory disorders

Scientists have observed for the first time what it looks like in the key memory region of the brain when a mistake is made during a memory trial.

9 Jun 2021

Weak brain signals may be an early warning sign of age-related neurodegenerative diseases

Weakened electrical signals in the brain may be an early warning sign of age-related neurodegenerative diseases such as Alzheimer's disease, suggests a study published today in eLife.

8 Jun 2021

Researchers identify genomic cellular map associated with hippocampal sclerosis

A multidisciplinary team led by researchers from the Spanish Research Council identifies the genomic cellular map associated with hippocampal sclerosis, a major histopathological condition of temporal lobe epilepsy.

8 Jun 2021

Brain study may lead to new treatments for neuro-immune conditions

The immune system is the brain's best frenemy. It protects the brain from infection and helps injured tissues heal, but it also causes autoimmune diseases and creates inflammation that drives neurodegeneration.

8 Jun 2021

FDA approves monoclonal antibody aducanumab for treating Alzheimer's patients

Today's FDA approval of the monoclonal antibody Aduhelm (aducanumab) to treat patients with Alzheimer's disease reflects years of significant advances in Alzheimer's research. This is the first new Alzheimer's drug approved in 17 years and the first shown to modify the course of the disease, which FDA believes will lead to slowing of patients' cognitive decline.

8 Jun 2021

New technology can explain the effect of genetic factors on brain structure, function

Liang Zhan, assistant professor of electrical and computer engineering at Pitt's Swanson School of Engineering, received a $500,000 CAREER award from the National Science Foundation to develop computational tools that improve our understanding of the human brain.

8 Jun 2021

Discovery offers a potential new pathway to treat hypertension

High blood pressure, or hypertension, is the leading modifiable risk factor for cardiovascular diseases and premature death worldwide.

7 Jun 2021

FDA grants accelerated approval for first-of-its-kind Alzheimer's treatment

Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer's, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments.

7 Jun 2021

Study identifies new drug to halt dementia in athletes after repeated head injuries

A world-first international study led by the University of South Australia has identified a new drug to stop athletes from developing dementia after sustaining repeated head injuries in their career.

7 Jun 2021

A single blood-based biomarker can help indicate underlying neurodegeneration

Levels of a protein called neurofilament light chain (NfL) in the blood can identify those who might have neurodegenerative diseases such as Down's syndrome dementia, motor neuron disease (ALS) and frontotemporal dementia, when clinical symptoms are not definitive

7 Jun 2021

Researchers uncover molecular mechanism linking Parkinson’s disease with COVID-19

The study findings reveal that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection results in abnormal modification of some lung proteins, which are subsequently transported to the brain via exosomes. In the brain, these modified lung proteins disrupt the normal functioning of proteins that are related to Parkinson’s disease.

7 Jun 2021

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Study identifies mechanisms by which COVID-19 can lead to Alzheimer's disease-like dementia

Study: cis P-tau is an early marker of vascular dementia, Alzheimer's disease

Experts call for new standards to prevent noise-induced hearing loss in younger generations

Age influences the extent to which smoking and other risk factors increase risk of depression

Systemic biomarkers show beneficial effects of aerobic exercise on brain function in older adults

Study reveals new insights into how genes are regulated in dementia

Nose-to-brain: Nasal delivery of biopharmaceuticals to the brain

Having trouble falling asleep associated with cognitive impairment 14 years later

Healthy behaviors can prevent dementia, finds study

New study has implications for research and advancements in Alzheimer’s and related memory disorders

Weak brain signals may be an early warning sign of age-related neurodegenerative diseases

Researchers identify genomic cellular map associated with hippocampal sclerosis

Brain study may lead to new treatments for neuro-immune conditions

FDA approves monoclonal antibody aducanumab for treating Alzheimer's patients

New technology can explain the effect of genetic factors on brain structure, function

Discovery offers a potential new pathway to treat hypertension

FDA grants accelerated approval for first-of-its-kind Alzheimer's treatment

Study identifies new drug to halt dementia in athletes after repeated head injuries

A single blood-based biomarker can help indicate underlying neurodegeneration

Researchers uncover molecular mechanism linking Parkinson’s disease with COVID-19

eBook: Hallmarks of Neurodegeneration eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Hallmarks of Neurodegeneration eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in